ReP USP - Resultado da busca

Switching from oral risperidone to flexibly dosed oral paliperidone extended-release: core symptoms, satisfaction, and quality of life in patients with stable but symptomatic schizophrenia: the RISPALI study (2014)

Gattaz, Wagner F.; Campos, João Alberto de Oliveira; Lacerda, Acioly L. T.; Henna, Elaine; Ruschel, Sandra Inês; Bressan, Rodrigo A.; Oliveira, Irismar Reis de; Rocha, Fábio Lopes; Grabowski, Hamilton M.; Sacomani Jr., Ernindo; Louzã, Mario R.; Quevedo, João; Elkis, Hélio; Zorzetto Filho, Dirceu; Périco, Cintia de Azevedo-Marques; Lawson, Fábio Lorea; Appolinário, José Carlos

Source: Current Medical Research and Opinions. Unidade: FM

Subjects: QUALIDADE DE VIDA, FARMACOTERAPIA, ESQUIZOFRENIA, ANTIPSICÓTICOS

A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

ABNT
GATTAZ, Wagner F. et al. Switching from oral risperidone to flexibly dosed oral paliperidone extended-release: core symptoms, satisfaction, and quality of life in patients with stable but symptomatic schizophrenia: the RISPALI study. Current Medical Research and Opinions, v. 30, n. 4, p. 695-709, 2014Tradução . . Disponível em: http://informahealthcare.com/doi/pdf/10.1185/03007995.2013.869201. Acesso em: 11 nov. 2024.
APA
Gattaz, W. F., Campos, J. A. de O., Lacerda, A. L. T., Henna, E., Ruschel, S. I., Bressan, R. A., et al. (2014). Switching from oral risperidone to flexibly dosed oral paliperidone extended-release: core symptoms, satisfaction, and quality of life in patients with stable but symptomatic schizophrenia: the RISPALI study. Current Medical Research and Opinions, 30( 4), 695-709. doi:10.1185/03007995.2013.869201
NLM
Gattaz WF, Campos JA de O, Lacerda ALT, Henna E, Ruschel SI, Bressan RA, Oliveira IR de, Rocha FL, Grabowski HM, Sacomani Jr. E, Louzã MR, Quevedo J, Elkis H, Zorzetto Filho D, Périco C de A-M, Lawson FL, Appolinário JC. Switching from oral risperidone to flexibly dosed oral paliperidone extended-release: core symptoms, satisfaction, and quality of life in patients with stable but symptomatic schizophrenia: the RISPALI study [Internet]. Current Medical Research and Opinions. 2014 ; 30( 4): 695-709.[citado 2024 nov. 11 ] Available from: http://informahealthcare.com/doi/pdf/10.1185/03007995.2013.869201
Vancouver
Gattaz WF, Campos JA de O, Lacerda ALT, Henna E, Ruschel SI, Bressan RA, Oliveira IR de, Rocha FL, Grabowski HM, Sacomani Jr. E, Louzã MR, Quevedo J, Elkis H, Zorzetto Filho D, Périco C de A-M, Lawson FL, Appolinário JC. Switching from oral risperidone to flexibly dosed oral paliperidone extended-release: core symptoms, satisfaction, and quality of life in patients with stable but symptomatic schizophrenia: the RISPALI study [Internet]. Current Medical Research and Opinions. 2014 ; 30( 4): 695-709.[citado 2024 nov. 11 ] Available from: http://informahealthcare.com/doi/pdf/10.1185/03007995.2013.869201

USP Schools

ReP

Filtros

Authors